Cory A. Gall, PhD
About Cory A. Gall, PhD
Cory A. Gall, PhD, is a Medical Science Liaison specializing in microbiome sciences, currently serving as an Extraordinary Lecturer at the University of Pretoria since 2021. He has extensive experience in infectious diseases and has transitioned from research roles to positions in biotech and pharmaceutical organizations.
Work at Aimmune Therapeutics
Cory A. Gall, PhD, serves as a Medical Science Liaison specializing in Microbiome at Aimmune Therapeutics. He has held this position since 2022, focusing on the west territory. His role involves covering a pre-launch pharmaceutical microbiome compound that targets rare diseases, including Clostridium difficile (C. diff).
Current Position at University of Pretoria
Since 2021, Cory A. Gall has been an Extraordinary Lecturer at the University of Pretoria, specifically at the Onderstepoort campus. His tenure in this role has lasted for three years, contributing to the academic environment and engaging with students in the field of microbiome sciences.
Previous Experience in Medical Science Liaison Roles
Cory A. Gall has extensive experience as a Medical Science Liaison. He worked at bioMérieux from 2020 to 2022, focusing on Infectious Diseases. Additionally, he held a brief position at EVERSANA in 2022 for three months, also in the Infectious Diseases sector. His roles have involved bridging the gap between clinical research and practical applications in healthcare.
Educational Background
Cory A. Gall holds a Doctor of Philosophy (PhD) in Immunology and Infectious Diseases from Washington State University, where he studied from 2012 to 2016. He also earned a Master of Science (MS) in Biology with a specialization in biotechnology from Old Dominion University, studying from 2010 to 2012. His undergraduate degree is a Bachelor of Science (BS) in Biology with a concentration in microbiology from Oakland University, completed from 2005 to 2009.
Research and Academic Contributions
Cory A. Gall has contributed to research in various capacities. He served as a Research Consultant at the University of Pretoria from 2018 to 2020 and was a Research Fellow at the Centers for Disease Control and Prevention in 2013. His academic journey includes roles as a Graduate Student and Postdoctoral Researcher at Washington State University, where he focused on infectious diseases and microbiome sciences.